Cancer immunotherapy
Whilst our understanding has advanced significantly in recent years, cancer’s heterogeneous and adaptive disease aetiology still poses a challenge to its treatment. To combat this, cancer immunotherapy covers a variety of approaches which artificially stimulate the patient’s own immune system to recognise and eliminate specific cancer cells. This Collection invites original research with a focus on cancer immunotherapy, as well as associated techniques and methods.
Editors
-
Andrew Craig
Queen's University, Canada
-
Marc S. Ernstoff
Roswell Park Comprehensive Cancer Center, USA
-
Hermann B. Frieboes
University of Louisville, USA
-
Paula Videira
FCT NOVA, Portugal
